252 related articles for article (PubMed ID: 14985462)
41. Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells.
Yamazaki R; Kusunoki N; Matsuzaki T; Hashimoto S; Kawai S
FEBS Lett; 2002 Nov; 531(2):278-84. PubMed ID: 12417326
[TBL] [Abstract][Full Text] [Related]
42. Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: implications on chemoprevention.
Yu J; Tang BD; Leung WK; To KF; Bai AH; Zeng ZR; Ma PK; Go MY; Hu PJ; Sung JJ
World J Gastroenterol; 2005 Jan; 11(1):41-5. PubMed ID: 15609394
[TBL] [Abstract][Full Text] [Related]
43. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
[TBL] [Abstract][Full Text] [Related]
44. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
[TBL] [Abstract][Full Text] [Related]
45. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
Niederberger E; Manderscheid C; Grösch S; Schmidt H; Ehnert C; Geisslinger G
Biochem Pharmacol; 2004 Jul; 68(2):341-50. PubMed ID: 15194006
[TBL] [Abstract][Full Text] [Related]
46. Docosahexaenoic acid in combination with celecoxib modulates HSP70 and p53 proteins in prostate cancer cells.
Narayanan NK; Narayanan BA; Bosland M; Condon MS; Nargi D
Int J Cancer; 2006 Oct; 119(7):1586-98. PubMed ID: 16646082
[TBL] [Abstract][Full Text] [Related]
47. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
Maier TJ; Schilling K; Schmidt R; Geisslinger G; Grösch S
Biochem Pharmacol; 2004 Apr; 67(8):1469-78. PubMed ID: 15041464
[TBL] [Abstract][Full Text] [Related]
48. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Sheng H; Shao J; Morrow JD; Beauchamp RD; DuBois RN
Cancer Res; 1998 Jan; 58(2):362-6. PubMed ID: 9443418
[TBL] [Abstract][Full Text] [Related]
49. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer.
Fu SL; Wu YL; Zhang YP; Qiao MM; Chen Y
World J Gastroenterol; 2004 Jul; 10(13):1971-4. PubMed ID: 15222049
[TBL] [Abstract][Full Text] [Related]
50. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.
Cianchi F; Cortesini C; Magnelli L; Fanti E; Papucci L; Schiavone N; Messerini L; Vannacci A; Capaccioli S; Perna F; Lulli M; Fabbroni V; Perigli G; Bechi P; Masini E
Mol Cancer Ther; 2006 Nov; 5(11):2716-26. PubMed ID: 17121918
[TBL] [Abstract][Full Text] [Related]
52. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
Elder DJ; Halton DE; Hague A; Paraskeva C
Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
[TBL] [Abstract][Full Text] [Related]
53. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor.
Moalic S; Liagre B; Le Bail JC; Beneytout JL
Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483
[TBL] [Abstract][Full Text] [Related]
54. Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma.
Denkins Y; Kempf D; Ferniz M; Nileshwar S; Marchetti D
J Lipid Res; 2005 Jun; 46(6):1278-84. PubMed ID: 15772428
[TBL] [Abstract][Full Text] [Related]
55. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells.
Suh YJ; Chada S; McKenzie T; Liu Y; Swisher SG; Lucci A; Hunt KK
Surgery; 2005 Sep; 138(3):422-30. PubMed ID: 16213894
[TBL] [Abstract][Full Text] [Related]
56. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
[TBL] [Abstract][Full Text] [Related]
57. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
Dandekar DS; Lopez M; Carey RI; Lokeshwar BL
Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368
[TBL] [Abstract][Full Text] [Related]
58. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
59. Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents.
Zhu J; Song X; Lin HP; Young DC; Yan S; Marquez VE; Chen CS
J Natl Cancer Inst; 2002 Dec; 94(23):1745-57. PubMed ID: 12464646
[TBL] [Abstract][Full Text] [Related]
60. Cyclooxygenase (COX)-2 and granulosa cell apoptosis in vitro.
Caffrey AS; Patton WC; Corselli JU; Swensen RE; King A; Chan PJ
J Assist Reprod Genet; 2002 Dec; 19(12):577-81. PubMed ID: 12503890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
